The prophylactic administration of recombinant erythropoietin in the management of ovarian cancer: time for a definitive phase 3 randomized trial.
Markman
Maurie
M
D000740:Anemia / Q000150:complications / Q000517:prevention & control*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin